A randomised clinical trial comparing interferon-α and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM

Journal of Neurology Neurosurgery and Psychiatry

Volumn 63, Issue 1, 1997, Pages 28-34

  Mariette, Xavier ^a,b   Chastang, Claude ^b   Clavelou, Pierre ^c   Louboutin, Jean Pierre ^d   Leger, Jean Marc ^e   Brouet, Jean Claude ^a  

^a Service d'Immuno Hématologie   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Hopital Fontmaure   (France)

^d CHU de Nantes   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antimyelin associated glycoprotein antibody; Interferon ; Intravenous immunoglobulin; Monoclonal IgM gammapathy; Polyneuropathy

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; MYELIN ASSOCIATED GLYCOPROTEIN; PARAPROTEIN; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ARM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTOR NERVE CONDUCTION; MULTICENTER STUDY; POLYNEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSORY NERVE CONDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 8544267922     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.63.1.28     Document Type: Article

References (37)

1. Latov N. Waldenstrom's macroglobulinemia and non-malignant IgM monoclonal gammapathies. In: Kelly JJ, Kyle RA, Latov N, eds. Polyneuropathies associated with plasma cell dyscrasia. Boston: Martinus Nijhoff, 1987:51-72.
2. Smith IS, Kahn SN, Lacey BW, et al. Chronic demyelinating neuropathy associated with benign IgM paraproteinemia. Brain 1983;106:169-95.
3. Dellagi K, Dupouey P, Brouet JC, et al. Waldenstrom's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients. Blood 1983;62:280-5.
4. Latov N, Sherman WH, Nemni R, et al. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med 1980;303:618-21.
5. Braun PE, Frail DE, Latov N. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem 1982;39:1261-5.
6. Chou DKH, Ilyas AA, Evans JE, et al. Structure of a glycolipid reacting with monoclonal IgM in neuropathy and with HNK1. Biochem Biophys Res Commun 1985;128:283.
7. Hauttecœur B, Schmitt C, Dubois C, et al. Reactivity of human monoclonal IgM with nerve glycosphingolipids. Clin Exp Immunol 1990;80:181-5.
8. Jauberteau MO, Henin D, Bouche P, et al. Etude des anticorps anti-glycolipides au cours des dysglobulinémies monoclonales à IgM associées à une neuropathie périphérique. Rev Neurol 1988;144:474-80.
9. Bollensen E, Steck A, Schachner M. Reactivity of the peripheral myelin glycoprotein PO in serum from patients with monoclonal IgM gammapathy and polyneuropathy. Neurology 1988;38:1266-70.
10. Mendell JR, Sahenk Z, Whitaker JN, et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenic role of anti-myelin-associated glycoprotein antibody. Ann Neurol 1985;17:243-54.
11. Monaco S, Bonetti B, Ferrari S, et al. Complementmediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N Engl J Med 1990;322: 649-52.
12. Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelinassociated glycoprotein. Ann Neurol 1993;33:502-6.
13. Dancea S, Dellagi K, Renaud F, et al. Effect of passive transfer of human anti-myelin-associated glycoprotein IgM in marmoset. Autoimmunity 1989;3:29-37.
14. Hays AP, Latov N, Takatsu M, Sherman WH. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M protein. Neurology 1987;37:242-56.
15. Nobile-Orazio E, Baldini L, Barbieri S, et al. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol 1988;24:93-7.
16. Oksenhendler E, Chevret S, Léger JM, et al for the IgM-associated Polyneuropathy Study group. Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J Neurol Neurosurg Psychiatry 1995;59:243-7.
17. Dyck PJ, Low PA, Windebank AJ, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991;325: 1482-6.
18. Cook D, Dalakas M, Galdi A, et al. High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 1990;40:212-4.
19. Léger JM, Ben Younes-Chennoufi A, Chassande B, et al. Treatment with human immunoglobulin of multifocal motor neuropathy and of polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 1995;57(suppl):46-9.
20. Rotoli B, De Renzo A, Frigeri F, et al. A phase II trial on α-interferon (αIFN) effect in patients with monoclonal IgM gammopathy. Leuk Lymphoma 1994;13:463-9.
21. Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with α interferon. Am J Med 1987;83:726-30.
22. Fest T, de Wazières B, Lamy B, et al. Successful response to α-interferon 2b in a refractory IgM autoagglutinin-mediated hemolytic anemia. Ann Hematol 1994;69:147-9.
23. Levy Y, Fermand JP, Navarro S, et al. Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammapathy. Proc Natl Acad Sci USA 1990;87:3309-13.
24. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbital, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-6.
25. Dyck PJ, Daube J, O'Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyneuropathy. N Engl J Med 1986;314:461-5.
26. Pocock SJ. Group sequencial methods in the design and analysis of clinical trials. Biometrika 1977;64:191-9.
27. Steck AJ, Murray N, Dellagi K, et al. Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol 1987;22:764-7.
28. Kazatchkine MD, Dietrich G, Hurez V, et al. V region-mediated selection of autoreactive repertoires by intravenous immunogloublin (iv Ig). Immunological Rev 1994;139:1-29.
29. Van der Meché FGA, Schmitz PIM, and the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-9.
30. Van Doorn PA, Brand A, Strengers PFW, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 1990;40:209-12.
31. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy : response to human immune globulin. Ann Neurol 1993;33:2437-42.
32. Gastineau DA, Habermann TM, Hermann RC. Severe neuropathy associated with low-dose recombinant interferon-α. Am J Med 1989;87:116.
33. Misiani R, Bellavita P, Fenili D, et al. Interferon α-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-6.
34. Shenoy M, Baron S, Wu B, Goluszko E, Christadoss P. IFN-a treatment suppresses the development of experimental autoimmune myasthenia gravis. Immunol 1995;154: 6203-8.
35. Gutterman JU. Cytokine therapeutics: lessons from interferon α. Proc Natl Acad Sci USA 1994;91:1198-205.
36. Upadhyaya G, Guba SC, Sih SA, et al. Interferon-α restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest 1991;88:2131-6.
37. Kanda T, Yoshino H, Ariga T, Yamawaki M, Yu RK. Glycosphingolipid antigens in cultured microvascular bovine brain endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. Cell Biol 1994;126:235-46.